Orthopedic Executives See Encouraging Trends in 1Q24 Executive Insights Industry Voices Leaders from the top orthopedic companies reflect on the market environment, the expanding importance of technology and M&A strategy. Jun 03, 2024
5 Takeaways from the 2024 ORTHOPAEDIC INDUSTRY ANNUAL REPORT Market Analysis The Numbers Get the latest orthopedic market sales data and analysis from the 2024 edition of THE ORTHPAEDIC INDUSTRY ANNUAL REPORT. May 30, 2024
Medtronic’s Winning Formula in Spine Company Revenue The Numbers The company leveraged it's differentiated and broad enabling technology ecosystem to drive implant and biologics sales growth. May 29, 2024
Smith+Nephew’s US Performance Lagging Peers Company Revenue The Numbers The company grew in the low-single-digits in the first quarter of 2024 as supply and commercial struggles in the U.S. offset other growth. May 28, 2024
Orthopedic Companies Report Results for First Quarter 2024 Market Analysis The Numbers Stay up to date on the orthopedic market's 1Q performance in 2024 as we update this post with company sales data and industry developments. May 28, 2024
How Medacta Continues to Drive Above-Market Growth Executive Insights Industry Voices We spoke with Medacta CEO Francesco Siccardi about what is driving the company’s strong sales, knee replacement market shifts and orthopedic market opportunities. May 23, 2024
Enovis on Track for $1 Billion Recon Business Chart of the Month The Numbers Enovis' reconstructive segment accounted for just 22% of sales in 2019. It will account for nearly 50% as it reaches $1 billion in 2024. May 15, 2024
OrthoPediatrics Reports Improving Surgical Environment Company Revenue The Numbers The company's orthopedic sales grew more than 22% in 1Q24 as volume and staffing improve in the pediatric market. May 15, 2024
Anika Therapeutics Reiterates 2024 Guide, Cuts Costs Company Revenue The Numbers The company's orthopedic sales grew in the mid-single-digits during 1Q24 as the company reduced headcount to control costs. May 14, 2024
Vericel Keeps Momentum Ahead of MACI Arthro Launch Company Revenue The Numbers The company's MACI sales grew nearly 18% in the first quarter of 2024 with the launch of MACI Arthro expected in the third quarter. May 14, 2024